American biopharmaceutical company headquartered in North Chicago, Illinois, created in 2013 when Abbott Laboratories spun off its research based pharmaceutical business, and enlarged by the acquisition of Allergan in 2020. Develops, manufactures and markets medicines in immunology, oncology, neuroscience, eye care, virology and women's health, including Humira, Skyrizi, Rinvoq, Imbruvica and Venclexta, together with the Botox and Juvederm aesthetics portfolio, and sells in more than a hundred and seventy countries.
暂无评论。
留下您的评分和评论